Primary Synchronous Ipsilateral Renal Fibrosarcoma and Renal Pelvic Carcinoma: A Case Report and Literature Review

References

• Gupta M, Bahri NU, Watal P, Chudasama SL, Brahmbhatt SG, Yant H. Malignant mesenchymal renal tumor: a rare case of primary renal fibrosarcoma. J Clin Imaging Sci. 2013;3:52. doi:10.4103/2156-7514.122322
   PubMedGoogle Scholar
• Agarwal K, Singh S, Pathania OP. Primary renal fibrosarcoma: a rare case report and review of literature. Indian J Pathol Microbiol. 2008;51(3):409–410. doi:10.4103/0377-4929.42541
   PubMed Web of Science ®Google Scholar
• Ares Valdés Y, Ares Valdés N, Contreras Duvelgel DM. [Renal fibrosarcoma. Report of a case]. Arch Esp Urol. 2003;56(9):1041–1043. (Spanish).
   PubMedGoogle Scholar
• Kaneoya F, Yoshida K, Horiuchi S, Negishi T. [A case of giant hydronephrosis caused by renal fibrosarcoma]. Hinyokika Kiyo. 1986;32(10):1505–1507. (Japanese).
   PubMedGoogle Scholar
• Chaudhari S, Hatwal D, Suri V. A rare case of primary fibrosarcoma of kidney. Iran J Kidney Dis. 2013;7(1):67–69.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhao S, Li G. Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: a case report. Medicine. 2020;99(47):e23263. doi:10.1097/MD.0000000000023263
   PubMed Web of Science ®Google Scholar
• Etiz D, Metcalfe E, Akcay M. Multiple primary malignant neoplasms: a 10-year experience at a single institution from Turkey. J Cancer Res Ther. 2017;13(1):16–20. doi:10.4103/0973-1482.183219
   PubMed Web of Science ®Google Scholar
• Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2020;113(2):70–84. doi:10.32074/1591-951X-213
   PubMed Web of Science ®Google Scholar
• Bahrami A, Folpe AL. Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010;34(10):1504–1513. doi:10.1097/PAS.0b013e3181ef70b6
   PubMed Web of Science ®Google Scholar
• Folpe AL. Fibrosarcoma: a review and update. Histopathology. 2014;64(1):12–25. doi:10.1111/his.12282
   PubMed Web of Science ®Google Scholar
• Mohamed M, Fisher C, Thway K. Low-grade fibromyxoid sarcoma: clinical, morphologic and genetic features. Ann Diagn Pathol. 2017;28:60–67. doi:10.1016/j.anndiagpath.2017.04.001
   PubMed Web of Science ®Google Scholar
• Torabi A, Corral J, Gatalica Z, Swensen J, Moraveji S, Bridge JA. Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature. Pathology. 2017;49(4):447–450. doi:10.1016/j.pathol.2017.01.010
   PubMed Web of Science ®Google Scholar
• Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18(2):184–187. doi:10.1038/ng0298-184
   PubMed Web of Science ®Google Scholar
• Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol. 2000;13(1):29–36. doi:10.1038/modpathol.3880006
   PubMed Web of Science ®Google Scholar
• Puls F, Agaimy A, Flucke U, et al. Recurrent fusions between YAP1 and KMT2A in morphologically distinct neoplasms within the spectrum of low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. 2020;44(5):594–606. doi:10.1097/PAS.0000000000001423
   PubMed Web of Science ®Google Scholar
• Argani P, Lewin JR, Edmonds P, et al. Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion. Am J Surg Pathol. 2015;39(3):365–373. doi:10.1097/PAS.0000000000000338
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Huang X, Ding L, Liu X, et al. Regulation of tumor microenvironment for pancreatic cancer therapy. Biomaterials. 2021;270:120680. doi:10.1016/j.biomaterials.2021.120680
   PubMed Web of Science ®Google Scholar
• Tazawa H, Okada F, Kobayashi T, et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol. 2003;163(6):2221–2232. doi:10.1016/S0002-9440(10)63580-8
   PubMed Web of Science ®Google Scholar
• Okada F, Nakai K, Kobayashi T, et al. Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells. Br J Cancer. 1999;79(3–4):377–385. doi:10.1038/sj.bjc.6690060
   PubMed Web of Science ®Google Scholar
• Borucki RB, Neskey DM, Lentsch EJ. Malignant fibrous histiocytoma: database review suggests a favorable prognosis in the head and neck. Laryngoscope. 2018;128(4):885–888. doi:10.1002/lary.26909
   PubMed Web of Science ®Google Scholar
• Robin YM, Penel N, Pérot G, et al. Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors. Mod Pathol. 2013;26(4):502–510. doi:10.1038/modpathol.2012.192
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang J. Primary malignant schwannoma of the heart. J Card Surg. 2019;34(4):211–213. doi:10.1111/jocs.14002
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Tsuchiya K, Fujisawa H. Intracranial low-grade fibromyxoid sarcoma: findings on electron microscopy and histologic analysis. World Neurosurg. 2020;135:301–305. doi:10.1016/j.wneu.2019.12.135
   PubMed Web of Science ®Google Scholar
• Rodrigues PF, Matarazzo S, Maccarinelli F, et al. Long pentraxin 3-mediated fibroblast growth factor trapping impairs fibrosarcoma growth. Front Oncol. 2018;8:472. doi:10.3389/fonc.2018.00472
   PubMed Web of Science ®Google Scholar
• Jain N, Das B, Mallick B. Restoration of microRNA-197 expression suppresses oncogenicity in fibrosarcoma through negative regulation of RAN. IUBMB Life. 2020;72(5):1034–1044. doi:10.1002/iub.2240
   PubMed Web of Science ®Google Scholar
• Ma H, Fang J, Wang T, et al. Efficacy and safety of Apatinib in the treatment of postoperative recurrence of fibrosarcoma. Onco Targets Ther. 2020;13:1717–1721. doi:10.2147/OTT.S214829
   PubMed Web of Science ®Google Scholar